Tissue factor/factor VIIa pathway mediates coagulation activation in induced-heat stroke in the baboon

Critical Care Medicine

Volumn 40, Issue 4, 2012, Pages 1229-1236

  Bouchama, Abderrezak ^a   Al Mohanna, Falah ^b   Assad, Lina ^c   Baturcam, Engin ^d   Eldali, Abdelmoneim ^c   Owaidah, Tarek ^c   Dehbi, Mohammed ^d  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b Department of Comparative Medicine ^*  (Saudi Arabia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d DASMAN DIABETES INSTITUTE   (Kuwait)

Author keywords

disseminated intravascular coagulation; fibrinolysis; heat stress; hyperthermia; inflammation

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 7A; D DIMER; FIBRIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; RECOMBINANT NEMATODE ANTICOAGULANT PROTEIN C2; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; SODIUM CHLORIDE; THROMBIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BABOON; BLOOD CLOTTING; CELL DAMAGE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; FIBRINOLYSIS; HEAT STRESS; HEAT STROKE; INCUBATION TEMPERATURE; INCUBATOR; INFLAMMATION; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; SAUDI ARABIA; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE; WARMING;

ANIMALS; BLOOD COAGULATION; BLOOD GAS ANALYSIS; FACTOR VIIA; HEAT STROKE; HELMINTH PROTEINS; INFLAMMATION; PAPIO HAMADRYAS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RECOMBINANT PROTEINS; THROMBOMODULIN; THROMBOPLASTIN;

EID: 84858763980     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182387bef     Document Type: Article

References (39)

1. Bouchama A, Knochel JP: Heat stroke. N Engl J Med 2002; 346:1978-1988
2. Robine JM, Cheung SL, Le Roy S, et al: Death toll exceeded 70, 000 in Europe during the summer of 2003. C R Biol 2008; 331:171-178
3. Fouillet A, Rey G, Laurent F, et al: Excess mortality related to the august 2003 heat wave in France. Int Arch Occup Environ Health 2006; 80:16-24
4. Jones TS, Liang AP, Kilbourne EM, et al: Morbidity and mortality associated with the July 1980 heat wave in St. Louis and Kansas City, MO. JAMA 1982; 247:3327-3331
5. Meikle AW, Graybill JR: Fibrinolysis and hemorrhage in a fatal case of heat stroke. N Engl J Med 1967; 276:911-913
6. Malamud N, Haymaker W, Custer R: Heatstroke: A clinico-pathologic study of 125 fatal cases. Milit Surg 1946; 99:397-449
7. Sohal RS, Sun SC, Colcolough HL, et al: Heat stroke. An electron microscopic study of endothelial cell damage and disseminated intravascular coagulation. Arch Intern Med 1968; 122:43-47
8. Chao TC, Sinniah R, Pakiam JE: Acute heat stroke deaths. Pathology 1981; 13:145-156
9. el-Kassimi FA, Al-Mashhadani S, Abdullah AK, et al: Adult respiratory distress syndrome and disseminated intravascular coagulation complicating heat stroke. Chest 1986; 90:571-574
10. al-Mashhadani SA, Gader AG, al Harthi SS, et al: The coagulopathy of heat stroke: Alterations in coagulation and fibrinolysis in heat stroke patients during the pilgrimage (Haj) to Makkah. Blood Coagul Fibrinolysis 1994; 5:731-736
11. Dematte JE, O'Mara K, Buescher J, et al: Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med 1998; 129:173-181
12. Misset B, De Jonghe B, Bastuji-Garin S, et al: Mortality of patients with heatstroke admitted to intensive care units during the 2003 heat wave in France: A national multiple-center risk-factor study. Crit Care Med 2006; 34:1087-1092
13. Bouchama A, Kunzelmann C, Dehbi M, et al: Recombinant activated protein c attenuates endothelial injury and inhibits procoagulant microparticles release in baboon heatstroke. Arterioscler Thromb Vasc Biol 2008; 28:1318-1325
14. Chen CM, Hou CC, Cheng KC, et al: Activated protein c therapy in a rat heat stroke model. Crit Care Med 2006; 34:1960-1966
15. Pawlinski R, Pedersen B, Schabbauer G, et al: Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004; 103:1342-1347
16. Creasey AA, Chang AC, Feigen L, et al: Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993; 91:2850-2860
17. Welty-Wolf KE, Carraway MS, Miller DL, et al: Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med 2001; 164:1988-1996
18. Geisbert TW, Hensley LE, Jahrling PB, et al: Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: A study in rhesus monkeys. Lancet 2003; 362:1953-1958
19. Huisse MG, Pease S, Hurtado-Nedelec M, et al: Leukocyte activation: The link between inflammation and coagulation during heatstroke. A study of patients during the 2003 heat wave in Paris. Crit Care Med 2008; 36:2288-2295
20. Roberts GT, Ghebeh H, Chishti MA, et al: Microvascular injury, thrombosis, inflammation, and apoptosis in the pathogenesis of heatstroke: A study in baboon model. Arterioscler Thromb Vasc Biol 2008; 28:1130-1136
21. Levi M: Burning issues surrounding inflammation and coagulation in heatstroke. Crit Care Med 2008; 36:2455-2456
22. Bergum PW, Cruikshank A, Maki SL, et al: Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2. J Biol Chem 2001; 276:10063-10071
23. Vlasuk GP, Rote WE: Inhibition of factor VIIa/tissue factor with nematode anticoagulant protein c2: From unique mechanism to a promising new clinical anticoagulant. Trends Cardiovasc Med 2002; 12:325-331
24. Cunningham MA, Romas P, Hutchinson P, et al: Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 1999; 94:3413-3420
25. Camerer E, Huang W, Coughlin SR: Tissue factor-and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Nat Acad Sci USA 2000; 97:5255-5260
26. de Jonge E, Friederich PW, Vlasuk GP, et al: Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects. Clin Diagn Lab Immunol 2003; 10:495-497
27. Bouchama A, Roberts G, Al Mohanna F, et al: Inflammatory, hemostatic, and clinical changes in a baboon experimental model for heatstroke. J Appl Physiol 2005; 98:697-705
28. Moons AH, Peters RJ, Cate H, et al: Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees. Thromb Haemost 2002; 88:627-631
29. Vlasuk GP, Bradbury A, Lopez-Kinninger L, et al: Pharmacokinetics and anticoagulant properties of the factor VIIa-tissue factor inhibitor recombinant nematode anticoagulant protein c2 following subcutaneous administration in man. Dependence on the stoichiometric binding to circulating factor X. Thromb Haemost 2003; 90:803-812
30. de Pont AC, Moons AH, de Jonge E, et al: Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia. J Thromb Haemost 2004; 2:65-70
31. Bouchama A, Ollivier V, Roberts G, et al: Experimental heatstroke in baboon: Analysis of the systemic inflammatory response. Shock 2005; 24:332-335
32. Bouchama A, Bridey F, Hammami MM, et al: Activation of coagulation and fibrinolysis in heatstroke. Thromb Haemost 1996; 76:909-915
33. de Jonge E, Dekkers PE, Creasey AA, et al: Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood 2000; 95:1124-1129
34. van der Poll T, Levi M, Buller HR, et al: Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991; 174:729-732
35. Jansen PM, Boermeester MA, Fischer E, et al: Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase a2 in sepsis: Studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia. Blood 1995; 86:1027-1034
36. van der Poll T, Jansen PM, Van Zee KJ, et al: Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor. Blood 1996; 88:922-927
37. Bouchama A, Kwaasi A, Dehbi M, et al: Glucocorticoids do not protect against the lethal effects of experimental heatstroke in baboons. Shock 2007; 27:578-583
38. Welty-Wolf KE, Carraway MS, Ortel TL, et al: Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol Lung Cell Mol Physiol 2006; 290:L21-L31
39. Carraway MS, Welty-Wolf KE, Miller DL, et al: Blockade of tissue factor: Treatment for organ injury in established sepsis. Am J Respir Crit Care Med 2003; 167:1200-1209